ALLENA PHARMACEUTICALS INC's ticker is ALNA and the CUSIP is 018119107. A total of 2 filers reported holding ALLENA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $16,000 | +300.0% | 83,827 | +501.6% | 0.00% | – |
| Q1 2022 | $4,000 | -88.6% | 13,934 | -76.8% | 0.00% | – |
| Q4 2021 | $35,000 | +2.9% | 59,999 | +59.2% | 0.00% | – |
| Q3 2021 | $34,000 | +1033.3% | 37,686 | +1407.4% | 0.00% | – |
| Q2 2021 | $3,000 | -76.9% | 2,500 | -74.4% | 0.00% | – |
| Q1 2021 | $13,000 | +85.7% | 9,774 | +26.0% | 0.00% | – |
| Q1 2020 | $7,000 | -46.2% | 7,757 | +138.1% | 0.00% | – |
| Q3 2019 | $13,000 | – | 3,258 | +11966.7% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 27 | -99.5% | 0.00% | – |
| Q4 2018 | $30,000 | 0.0% | 5,488 | +97.4% | 0.00% | – |
| Q3 2018 | $30,000 | -36.2% | 2,780 | -23.7% | 0.00% | – |
| Q2 2018 | $47,000 | +135.0% | 3,645 | +84.7% | 0.00% | – |
| Q4 2017 | $20,000 | – | 1,974 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 2,263,365 | $20,493,000 | 82.81% |
| Pharmstandard International S.A. | 1,037,267 | $10,435,000 | 10.73% |
| Partner Investment Management, L.P. | 575,407 | $4,724,000 | 5.44% |
| FRAZIER MANAGEMENT LLC | 3,330,373 | $33,504,000 | 5.43% |
| TRV GP II, LLC | 2,790,964 | $28,077,000 | 5.06% |
| SPHERA FUNDS MANAGEMENT LTD. | 325,000 | $3,270,000 | 0.38% |
| PFM Health Sciences, LP | 1,464,204 | $13,255,000 | 0.31% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 605,100 | $6,087,000 | 0.24% |
| Perceptive Advisors | 250,000 | $2,515,000 | 0.08% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 18,288 | $259,000 | 0.07% |